NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

Flexroy,

Yep and even though the journal article and TLD had an outside chance by SNO last year and should have been done earlier this year, the move to get the ASM positioned around ASCO for several years was telling me something. Linda spoke about ASCO last year as a time not to raise expectations reenforcing a sense that the journal was not ready and that manufacturing preparedness had risen past a litmus test to the top priority. Any words of caution like that this year?; ). Final countdown. Best wishes.